Wells Fargo & Company »

Avadel Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 102k 15.27
2025-06-30 $809k 91k 8.85
2025-03-31 $659k 84k 7.83
2024-12-31 $874k 83k 10.51
2024-09-30 $963k 73k 13.12
2024-06-30 $1.2M 88k 14.06